Towards a Personalized Medicine for the Diagnosis and Management of Gynecological Cancers
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Causes, Screening and Diagnosis".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 228
Special Issue Editors
Interests: endometriosis; laparoscopic surgery; gynecologic oncology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue is aimed toward developing personalized medicine for the diagnosis and management of gynecological cancers.
Gynecological cancers are the most commonly occurring form of cancer among women worldwide. They impact quality of life inaffected patients, disrupt women’s reproductive systems, and have a limited response to treatment at an advanced stage.
However, new technologies and research in the fields of prevention, diagnosis, and treatment are changing this context by supporting both specialists and the patient during their medical journey.
In an ever-more digital- and AI-oriented era, the main challenge of professionals is to tailor the diagnosis and treatment experience to suit individual patients by personalizing medicine used in the management of gynecological cancer women.
Aiming to ensure the right course of treatment for each patient, the scope of this Special Issue includes, but is not limited to, the following topics:
- Selected prevention of oncological diseases;
- Specific diagnostic workup of gynecological cancer;
- Tailoring treatments according to patient and cancer characteristics;
- Assessment performed via dedicated oncological follow-up.
Researchers working in the field of gynecological cancers are encouraged to submit original articles and reviews related to this Special Issue’s scope. Communications, systematic reviews, and meta-analyses are also welcome.
Dr. Diego Raimondo
Dr. Gabriele Centini
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
